TY  - JOUR

T1  - Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.

JO  - Clin Endocrinol (Oxf)

PY  - 2014/02/17

AU  - Pivonello R

AU  - Petersenn S

AU  - Newell-Price J

AU  - Findling JW

AU  - Gu F

AU  - Maldonado M

AU  - Trovato A

AU  - Hughes G

AU  - Salgado LR

AU  - Lacroix A

AU  - Schopohl J et al

ED  - 

DO  - DOI: 10.1111/cen.12431

VL  - 81

IS  - 3

SP  - 408

EP  - 417

Y2  - 2024/12/22

ER  -